CIK: 0001802528 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 15, 2022
Total Value ($000): $436,929 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | BIOHAVEN PHARMACTL HLDG CO | 264,206 | $38,497 | 8.8% | $125.18 | — | COM | G11196105 |
| AXSM | AXSOME THERAPEUTICS INC | 942,571 | $36,100 | 8.3% | $39.90 | -20.7% | COM | 05464T104 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 3,343,107 | $35,370 | 8.1% | $10.32 | 0.0% | COM | 09058V103 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 953,396 | $30,461 | 7.0% | $33.39 | — | COM | 37890U108 |
| ARGX | ARGENX SE | 73,526 | $27,858 | 6.4% | $266.01 | — | SPONSORED ADR | 04016X101 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 283,000 | $27,587 | 6.3% | $92.29 | 0.0% | COM | 64125C109 |
| INSM | INSMED INC | 1,326,368 | $26,156 | 6.0% | $23.15 | -9.5% | COM PAR $.01 | 457669307 |
| COGT | COGENT BIOSCIENCES INC | 2,758,975 | $24,886 | 5.7% | $9.18 | -25.6% | COM | 19240Q201 |
| NUVL | NUVALENT INC | 1,715,518 | $23,262 | 5.3% | $21.38 | -50.5% | COM | 670703107 |
| ENTA | ENANTA PHARMACEUTICALS INC | 469,264 | $22,182 | 5.1% | $60.43 | -10.2% | COM | 29251M106 |
| ONC | BEIGENE LTD | 111,400 | $18,030 | 4.1% | $161.85 | — | SPONSORED ADR | 07725L102 |
| — | CTI BIOPHARMA CORP | 2,245,891 | $13,408 | 3.1% | $5.97 | — | COM | 12648L601 |
| — | POINT BIOPHARMA GLOBAL INC | 1,833,950 | $12,489 | 2.9% | $7.41 | — | COM | 730541109 |
| — | DBV TECHNOLOGIES SA | 4,831,155 | $12,319 | 2.8% | $2.55 | — | SPONSORED ADR | 23306J101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 944,092 | $10,923 | 2.5% | $14.82 | -9.3% | COM | 92790C104 |
| ANNX | ANNEXON INC | 2,892,600 | $10,905 | 2.5% | $4.39 | -30.5% | COM | 03589W102 |
| OLMA | OLEMA PHARMACEUTICALS INC | 2,669,300 | $10,864 | 2.5% | $5.51 | -42.5% | COM | 68062P106 |
| ACAD | ACADIA PHARMACEUTICALS INC | 751,804 | $10,593 | 2.4% | $31.03 | -39.8% | COM | 004225108 |
| TYRA | TYRA BIOSCIENCES INC | 1,416,998 | $10,132 | 2.3% | $14.88 | -46.5% | COM | 90240B106 |
| — | AMARIN CORP PLC | 5,584,837 | $8,321 | 1.9% | $6.11 | — | SPONS ADR NEW | 023111206 |
| KROS | KEROS THERAPEUTICS INC | 272,498 | $7,529 | 1.7% | $54.40 | -19.3% | COM | 492327101 |
| TRVI | TREVI THERAPEUTICS INC | 1,624,389 | $4,565 | 1.0% | $2.46 | 0.0% | COM | 89532M101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 389,588 | $4,301 | 1.0% | $24.87 | -47.3% | COM | 462260100 |
| — | VERONA PHARMA PLC | 926,602 | $3,882 | 0.9% | $5.55 | — | SPONSORED ADS | 925050106 |
| — | INSTIL BIO INC | 673,905 | $3,113 | 0.7% | $24.02 | — | COM | 45783C101 |
| — | ASTRIA THERAPEUTICS INC | 911,736 | $2,735 | 0.6% | $8.84 | — | COM | 04635X102 |
| — | ALLAKOS INC | 147,189 | $461 | 0.1% | $84.51 | — | COM | 01671P100 |